FDA 510(k) Medical Device Registration Document Checklist

Answer: FDA 510(k) is a premarket notification for low- to moderate-risk medical devices. The submission must demonstrate substantial equivalence to a legally marketed predicate device. Core documents include: 1. FDA Form 3514, the 510(k) application form; 2. product description and intended use statement; 3. predicate device comparison table and substantial equivalence argument; 4. performance test reports (biocompatibility, electrical safety, software validation, etc.); 5. labels and instructions for use compliant with 21 CFR 801; 6. manufacturing process overview and quality system declaration (QSR 820); 7. clinical data, if applicable. Submissions are electronic through eCopy or eSubmitter. FDA generally reviews within 90 days and may request additional information. Note: products exempt from 510(k) must be confirmed against the exemption list.

Published: 2026-07-08 09:00; Updated: 2026-07-08 09:00.

This article organizes the issues medical device companies should prioritize in international registration, document preparation, compliance pathways, and post-market maintenance.

Key Summary

FDA 510(k) registration is a premarket notification for low- to moderate-risk medical devices and requires demonstration of substantial equivalence to a legally marketed predicate device. The core materials include: 1. 510(k) application form (Form 3514); 2. product description and intended use statement; 3. predicate device comparison table and substantial equivalence argument; 4. performance test reports (biocompatibility, electrical safety, software validation, etc.); 5. labels and instructions for use (compliant with 21 CFR 801); 6. manufacturing process overview and quality system declaration (QSR 820); 7. clinical data, if applicable. The submission method is electronic submission (eCopy or eSubmitter). FDA generally reviews within 90 days and may request additional information. Note: products exempt from 510(k) must be confirmed against the exemption list.

Applicable Scenarios and Core Questions

Clients are most concerned about the 510(k) timeline and success rate, and how to select an appropriate predicate device. They worry that incomplete documents may cause review delays or rejection. They also want to know whether clinical data are required and how to respond to FDA deficiency questions. Labeling and manufacturing quality system compliance are also key concerns.

Registration Judgment Logic

First confirm whether the product falls within a 510(k)-exempt category (see 21 CFR 862-892). If not exempt, identify a predicate device with similar intended use and technical characteristics. If multiple predicates exist, choose the closest one and submit a comparison table. If the product is novel or has no equivalent, De Novo classification or PMA may be required. Key criteria include indications, technological principles, materials, and performance parameters.

Core Documents and Evidence

• Application form: Form 3514, including product identification code and manufacturer information.
• Comparison table: detailed comparison of similarities and differences between the product and predicate, explaining substantial equivalence.
• Test reports: biocompatibility (ISO 10993), electrical safety (IEC 60601), software validation (IEC 62304), etc.
• Labeling: compliant with 21 CFR 801, including instructions for use, warnings, and contraindications.
• Manufacturing information: manufacturing flow chart and declaration of quality system compliance with QSR 820.
• Clinical data: if required, submit clinical trial summaries or literature.

Common Errors

• Failure to correctly identify the predicate device, leading to insufficient argumentation.
• Incomplete test reports or mismatched standards (e.g., using outdated versions).
• Labels missing required information or not in the required language (English).
• Quality system documents not provided as required or failure to pass an inspection.
• Electronic submission format errors (e.g., eCopy not compliant with FDA guidance).

Company Preparation Checklist

• Develop an internal project plan with clear responsibilities.
• Complete all performance tests and obtain reports.
• Draft product labels and instructions for use.
• Organize quality system documents (e.g., design control documents).
• Select an appropriate predicate device and prepare a comparative analysis.
• Build a regulatory team or engage consultants for pre-review.

AIMEILI Perspective

In AIMEILI's regulatory practice, the most common cause of delay is not the absence of testing, but weak predicate selection and incomplete substantial equivalence logic. A strong 510(k) strategy aligns intended use, technological characteristics, and performance data early, and treats labeling and QSR 820 evidence as part of the core submission rather than ancillary documents. For manufacturers, this reduces deficiency cycles, improves review predictability, and supports timely U.S. market entry.

Common Follow-up Questions

Q: How long does a 510(k) take?

A: Generally 90 days, but in practice it may extend to 6 months due to additional questions.

Q: What if the predicate device has been discontinued?

A: Its marketing data may still be used, but its legal status must be confirmed.

Q: Is third-party review mandatory?

A: Some Class III devices may involve third-party review; Class II 510(k)s are usually reviewed directly by FDA.

Continue Reading

Previous: Thailand Medical Device Registration Process: Classification, Documents, Submission Pathways, and Corporate Preparation Points?

Next: U.S. FDA Medical Device Cybersecurity Registration Requirements?

Recommended reading: U.S. FDA Medical Device Cybersecurity Registration Requirements?; What Should Companies Prepare Before Australian TGA Medical Device Registration?; Can Singapore HSA Medical Device Registration Reuse CE Documentation?; What Core Documents Are Required for UAE MOHAP Medical Device Registration?; Why Is Brazil ANVISA Medical Device Registration So Long?; What Is the Difference Between a Vietnam Medical Device Import License and Registration Certificate?

Back to FAQ Center | News | Contact AIMEILI

Content Review and Applicable Boundaries

Content author: AIMEILI Regulatory Editorial Team. Professional review: AIMEILI Medical Device International Registration Project Team. Source principle: prioritize official regulatory agencies, international organizations, standards organizations, and public regulatory materials; industry media and project experience are used only as supplementary judgment. Applicable boundary: This article is for preliminary understanding, document preparation, and project planning. It does not replace the formal requirements of the target country regulator, testing conclusions, or legal advice.

Compiled from AIMEILI regulatory practice question bank, medical device international registration knowledge base, and public regulatory information; specific projects should be based on the latest requirements of the target country regulator and product data.